Weight & Metabolic Health
-
When GLP-1 Weight Loss Changes the Scale but Not the Body You Expected
Losing weight can change your health without creating the body you pictured when you started. That…
-
What Recent Reddit Posts Reveal About GLP-1 Weight Loss, Retatrutide, and Menopause
Recent Reddit discussions show that weight-loss questions are rarely only about the scale. People describe food…
-
Eloralintide Explained: Amylin Research, Trial Evidence, and FDA Status
Eloralintide (LY3841136) is an investigational selective amylin-receptor agonist being studied for obesity and related conditions. Phase…
-
Retatrutide Explained: Trial Evidence, Risks, and FDA Status
Retatrutide (LY3437943) is an investigational agonist of GIP, GLP-1, and glucagon receptors. It has produced substantial…
-
Tirzepatide Explained: Approved Uses, Evidence, Risks, and Online Claims
Tirzepatide is a GIP/GLP-1 receptor agonist used in FDA-approved prescription products for specific indications. Approved Mounjaro…
-
Semaglutide Explained: Approved Uses, Evidence, Risks, and Online Claims
Semaglutide is a GLP-1 receptor agonist used in FDA-approved prescription products for specific metabolic and cardiovascular…